When was LiteFold founded?

LiteFold was founded in 2025 and raised its 1st funding round 1 year after it was founded.

Where is LiteFold located?

LiteFold is headquartered in Dover, United States.

How many employees does LiteFold have?

As of Jun 30, 2026, the latest employee count at LiteFold is 6.

Is LiteFold a funded company?

LiteFold is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on May 13, 2026.

When was the latest funding round of LiteFold?

LiteFold's latest funding was a $***** Seed round on May 13, 2026, with participation from 1 investor. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $3.34B in funding in 2026 to date.

Where does LiteFold rank among its competitors?

LiteFold ranks 5th amongst 10 active competitors, of which 4 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was LiteFold, which secured an undisclosed amount in May, 2026.

Who are the top competitors of LiteFold?

LiteFold's top competitors include TernaryTx, Avilar and Epsilico. Among them, LiteFold secured the most recent funding round in May, 2026.

LiteFold - 2026 Company Profile, Team, Funding & Competitors

Company Details

AI platform focused on accelerating protein engineering and drug discovery workflows. It provides accessible tools for researchers to predict, visualize, and analyze protein structures using advanced models like AlphaFold2 and ESM3.

Website: litefold.in
Social
Email ID: *****@litefold.ai

Key Metrics

Founded Year

2025

Location

Dover, United States

Stage

Seed

Latest Funding Round

Seed, May 13, 2026, $*****

Investors

3F VC & 1 more

Ranked

5^th among 10 active competitors

Employee Count

6 as on Jun 30, 2026

Similar Companies

OpenEvidence & 2846 more

View LiteFold's full profile

LiteFold has raised funding over 2 rounds. Its first funding round was on May 13, 2026. Its latest funding round was a Seed round on May 13, 2026 for $*****. 1 investor participated in its latest round. LiteFold has 2 institutional investors.

Here is the list of recent funding rounds of LiteFold:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 13, 2026	8338361	Seed	2396095	1145097	9342670	1986237
May 13, 2026	6919452	Grant (prize money)	1667975	1769198	4431641	Mercatus

Access funding benchmarks and valuations. Sign up today!

View details of LiteFold's funding rounds and investors

The founders of LiteFold are Anindyadeep Sannigrahi and Cory Kornowicz.

Here are the details of LiteFold's key team members:

Anindyadeep Sannigrahi: Co-Founder of LiteFold.
Cory Kornowicz: Co-Founder of LiteFold.

View details of LiteFold's Founder profiles and Board Members

LiteFold's employee count trend

LiteFold has 6 employees as of Jun 26. Here is LiteFold's employee count trend over the years:

Uncover LiteFold's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of LiteFold include TernaryTx, Avilar and Epsilico. Here is the list of Top 10 competitors of LiteFold, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	TernaryTx 2024, London (United Kingdom), Seed	Developer of computational platform for molecular glue discovery and design	$4.76M	Daphni, Pace Ventures & 2 others	42/100
2nd	Avilar 2020, Waltham (United States), Seed	Provider of drug discovery platform and protein degradation technology	$75.3M	Sanofi Ventures, Astellas Venture Management ... & 2 others	40/100
3rd	Epsilico 2020, Berlin (Germany), Seed	Generative AI technology for designing biologics	-	Life Science Valley, Europa & 1 others	36/100
4th	iN Therapeutics 2020, Yongin (South Korea), Funding Raised	Developer of drugs for patients with rare neurological diseases	-	E&Venture Partners, Korea Omega Investment Corp	32/100
5th	LiteFold 2025, Dover (United States), Seed	AI platform focused on accelerating protein engineering and drug discovery workflows	-	3F VC, Mercatus	30/100
6th	Levitate Bio 2024, Kirkland (United States), Unfunded	Platform offering automated and customized AI solutions for biopharma drug discovery	-	-	26/100
7th	Interdict 2022, San Francisco (United States), Funding Raised	Developer of a small molecule therapeutics platform to address undruggable targets	-	Altitude Life Science Ventures	24/100
8th	Ubiquitx 2021, Cambridge (United States), Funding Raised	Developer of AI-powered platform for targeted protein degradation therapeutics design	-	E14 Fund, HHS	22/100
9th	FuturedMe 2018, Tokyo (Japan), Funding Raised	Developer of platform for protein degradation for development of small molecule based drug	-	JAFCO Group	22/100
10th	Adhesion Therapeutics 2024, Graz (Austria), Funding Raised	AI-enabled molecular glue degraders aimed at treating diseases	-	Europa	15/100